ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,925.29
0.05%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Lantheus Holdings Inc (LNTH)

  7. Lantheus Holdings Inc (LNTH) 뉴스

LNTH Lantheus Holdings Inc

75.99
-2.19 (-2.80%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Lantheus Holdings Inc LNTH 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-2.19 -2.80% 75.99 13:00:00
개장가 저가 고가 종가 전일 종가
78.00 74.95 79.97 75.53 78.18
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202420:00GLOBELantheus Reports First Quarter 2024 Financial Results
18/04/202421:00GLOBELantheus to Host First Quarter 2024 Earnings Conference Call..
12/03/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202400:46EDGAR2Form 144 - Report of proposed sale of securities
06/03/202410:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202422:30GLOBELantheus to Present at the Leerink Partners Global Biopharma..
05/03/202407:44EDGAR2Form 144 - Report of proposed sale of securities
04/03/202422:30GLOBELantheus Announces the FDA Approval of DEFINITY® (Perflutren..
28/02/202422:30GLOBELantheus Announces Promotion of Amanda Morgan to Chief..
26/02/202422:30GLOBELantheus to Present at the TD Cowen 44th Annual Health Care..
22/02/202421:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202421:47EDGAR2Form 8-K - Current report
22/02/202421:00GLOBELantheus Reports Fourth Quarter and Full Year 2023 Financial..
16/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202400:18EDGAR2Form 144 - Report of proposed sale of securities
13/02/202422:30GLOBELantheus Announces Collaboration to Provide Novel Tau..
08/02/202422:00GLOBELantheus to Host Fourth Quarter and Full Year 2023 Earnings..
26/01/202421:59EDGAR2Form 8-K - Current report
23/01/202422:00EDGAR2Form 8-K - Current report
23/01/202421:45GLOBELantheus Announces CEO Succession Plan
19/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202402:05EDGAR2Form 144 - Report of proposed sale of securities
11/01/202422:00GLOBELantheus Announces Acceptance of its First-to-File ANDA for..
09/01/202422:00GLOBELantheus Expands Radiopharmaceutical Oncology Pipeline via..
09/01/202421:57EDGAR2Form 8-K - Current report
09/01/202421:55GLOBELantheus Reports Preliminary Fiscal Year 2023 Revenue
03/01/202422:30GLOBELantheus to Present at the 42nd Annual J.P. Morgan..
20/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202321:30GLOBELantheus and POINT Biopharma Announce Positive Topline..
16/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:18EDGAR2Form 144 - Report of proposed sale of securities
14/12/202302:06EDGAR2Form 144 - Report of proposed sale of securities
21/11/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202303:22EDGAR2Form 144 - Report of proposed sale of securities
16/11/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202305:45EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
LNTH
Lantheus
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유